News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
227,430 Results
Type
Article (7163)
Company Profile (16)
Press Release (220251)
Section
Business (63173)
Career Advice (294)
Deals (14781)
Drug Delivery (27)
Drug Development (36802)
Employer Resources (27)
FDA (6409)
Job Trends (4910)
News (121876)
Policy (11625)
Tag
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
Academia (566)
Accelerated approval (1)
Adcomms (7)
Allergies (35)
Alliances (14773)
ALS (26)
Alzheimer's disease (596)
Antibody-drug conjugate (ADC) (34)
Approvals (6447)
Artificial intelligence (97)
Autoimmune disease (10)
Automation (2)
Bankruptcy (147)
Best Places to Work (4609)
BIOSECURE Act (1)
Biosimilars (18)
Biotechnology (18)
Bladder cancer (45)
Brain cancer (14)
Breast cancer (99)
Cancer (1056)
Cardiovascular disease (67)
Career advice (258)
Career pathing (4)
CAR-T (85)
Cell therapy (208)
Cervical cancer (12)
Clinical research (31095)
Collaboration (287)
Compensation (81)
Complete response letters (7)
COVID-19 (722)
CRISPR (17)
C-suite (69)
Cystic fibrosis (36)
Data (1208)
Denatured (1)
Depression (18)
Diabetes (101)
Diagnostics (2223)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (10)
Drug discovery (43)
Drug pricing (41)
Drug shortages (17)
Duchenne muscular dystrophy (37)
Earnings (33241)
Editorial (13)
Employer branding (1)
Employer resources (21)
Events (30863)
Executive appointments (218)
FDA (7014)
Featured Employer (3)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (253)
Gene editing (44)
Generative AI (9)
Gene therapy (125)
GLP-1 (181)
Government (1251)
Grass and pollen (2)
Guidances (32)
Healthcare (6143)
Huntington's disease (4)
IgA nephropathy (13)
Immunology and inflammation (33)
Indications (15)
Infectious disease (779)
Inflammatory bowel disease (58)
Inflation Reduction Act (5)
Influenza (23)
Intellectual property (46)
Interviews (45)
IPO (8030)
IRA (17)
Job creations (572)
Job search strategy (221)
Kidney cancer (7)
Labor market (5)
Layoffs (40)
Leadership (3)
Legal (2098)
Liver cancer (37)
Lung cancer (147)
Lymphoma (71)
Machine learning (1)
Management (8)
Manufacturing (92)
MASH (35)
Medical device (4574)
Medtech (4575)
Mergers & acquisitions (7079)
Metabolic disorders (264)
Multiple sclerosis (37)
NASH (8)
Neurodegenerative disease (24)
Neuropsychiatric disorders (4)
Neuroscience (787)
NextGen: Class of 2025 (1499)
Non-profit (711)
Northern California (1198)
Obesity (133)
Opinion (73)
Ovarian cancer (53)
Pain (33)
Pancreatic cancer (45)
Parkinson's disease (61)
Partnered (4)
Patents (116)
Patient recruitment (55)
Peanut (17)
People (14472)
Pharmaceutical (8)
Pharmacy benefit managers (6)
Phase I (9925)
Phase II (13677)
Phase III (10264)
Pipeline (687)
Podcasts (3)
Policy (30)
Postmarket research (798)
Preclinical (3605)
Press Release (9)
Prostate cancer (46)
Psychedelics (11)
Radiopharmaceuticals (118)
Rare diseases (151)
Real estate (1006)
Recruiting (8)
Regulatory (9100)
Reports (13)
Research institute (509)
Resumes & cover letters (39)
Rett syndrome (3)
RNA editing (2)
RSV (14)
Schizophrenia (25)
Series A (41)
Series B (28)
Service/supplier (2)
Sickle cell disease (22)
Southern California (1044)
Special edition (2)
Spinal muscular atrophy (31)
Sponsored (14)
Startups (677)
Stomach cancer (5)
Supply chain (20)
Tariffs (1)
The Weekly (1)
United States (10010)
Vaccines (162)
Venture capitalists (5)
Webinars (1)
Weight loss (74)
Women's health (6)
Worklife (4)
Date
Today (44)
Last 7 days (387)
Last 30 days (1397)
Last 365 days (16130)
2025 (3884)
2024 (16934)
2023 (19107)
2022 (22271)
2021 (23654)
2020 (21815)
2019 (14454)
2018 (10645)
2017 (11463)
2016 (9554)
2015 (11751)
2014 (8108)
2013 (5886)
2012 (6060)
2011 (6762)
2010 (6228)
Location
Africa (176)
Alabama (15)
Alaska (2)
Arizona (51)
Arkansas (3)
Asia (17513)
Australia (4841)
California (2692)
Canada (1069)
China (223)
Colorado (117)
Connecticut (154)
Delaware (56)
Europe (27933)
Florida (393)
Georgia (67)
Idaho (6)
Illinois (194)
India (19)
Indiana (116)
Japan (86)
Kansas (14)
Kentucky (5)
Louisiana (4)
Maine (35)
Maryland (335)
Massachusetts (1943)
Michigan (50)
Minnesota (99)
Missouri (34)
Montana (11)
Nebraska (8)
Nevada (37)
New Hampshire (36)
New Jersey (929)
New Mexico (3)
New York (859)
North Carolina (380)
North Dakota (2)
Northern California (1198)
Ohio (58)
Oklahoma (1)
Oregon (7)
Pennsylvania (638)
Puerto Rico (4)
Rhode Island (7)
South America (301)
South Carolina (8)
Southern California (1044)
Tennessee (38)
Texas (405)
Utah (64)
Virginia (73)
Washington D.C. (16)
Washington State (331)
West Virginia (2)
Wisconsin (10)
227,430 Results for "quotient limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Collaboration
Pfizer Partners With Flagship’s Quotient to Leverage Genetics Against Heart, Renal Diseases
Quotient Therapeutics’ platform targets somatic mutations, which the startup contends can help identify a broader scope of genes potentially associated with disease phenotypes. Wednesday’s agreement is part of an existing partnership between Pfizer and Flagship Pioneering.
August 28, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Quotient Therapeutics Appoints Sir Mene Pangalos, Ph.D. to Board of Directors
November 8, 2024
·
3 min read
Press Releases
Quotient Therapeutics Appoints Peter Campbell, Ph.D. as Chief Scientific Officer
August 7, 2024
·
2 min read
Policy
Quotient Limited Announces Intent to Voluntary Delist from the Nasdaq Global Market
Quotient Limited announced that it has given formal notice to the Nasdaq Stock Market LLC of its intention to voluntarily delist its ordinary shares from the Nasdaq Global Market.
December 12, 2022
·
3 min read
Quotient Limited Announces Intent to Effect Reverse Stock Split
Quotient Limited, a commercial-stage diagnostics company, announced that it will effect a one-for-40 reverse stock split of its ordinary shares, nil par value that will become effective on November 2, 2022 at 5:01 p.m. Eastern Time, after the close of trading on The Nasdaq Global Market.
October 31, 2022
·
3 min read
Quotient Limited and Theradiag Announce Partnership to Advance Autoimmune Disease Diagnostics
Quotient Limited announced an agreement with Theradiag, a market leader in autoimmune disease testing and pioneer in theranostics, under which the two companies will partner to advance autoimmune diagnostics by leveraging Quotient’s MosaiQ platform.
June 8, 2022
·
7 min read
Quotient Limited Selected to Join the World Economic Forum New Champions Community
Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, announced it was selected by the World Economic Forum to join their New Champions Community.
September 8, 2022
·
3 min read
Press Releases
Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer
August 28, 2024
·
4 min read
Business
Quotient Limited and InfYnity Biomarkers Announce Partnership to Expand MosaiQ Infectious Disease Menu
Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced an agreement with InfYnity Biomarkers, an R&D firm dedicated to utilizing biomarkers for the management of infectious and immunology diseases, under which the two companies will partner to advance the safety and effectiveness of infectious disease testing by leveraging Quotient’s MosaiQ solution.
July 12, 2022
·
4 min read
Business
Quotient Limited Announces Opening of Office in Dubai, United Arab Emirates
Quotient Limited announced the opening of its new office in Dubai, UAE, and the incorporation of its subsidiary Quotient Middle-East and Africa FZ LLC, as part of its ongoing expansion plans to better support customers in the region.
May 17, 2022
·
4 min read
1 of 22,743
Next